Indiqube Spaces to host investor meet in Mumbai on Sep 8
- Indiqube Spaces to host investor meet on Sep 8, 2026
- Session starts at 10:00 am in Mumbai
- Format is one-on-one or group interaction
- Only publicly available info to be discussed
- No UPSI intended for discussion

*this image is generated using AI for illustrative purposes only.
Indiqube Spaces has scheduled an in-person meeting with analysts and institutional investors for Tuesday, September 8, 2026. The event will take place in Mumbai starting at 10:00 am.
The company issued the intimation on September 3, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Bhasker Dubey, Company Secretary and Compliance Officer, confirmed the schedule.
Meeting Details
The interaction is structured as a one-on-one or group meeting with a group of investors. Discussions will be limited to publicly available information.
| Date & Time | Interaction with | Nature of Meeting | Mode | Place |
|---|---|---|---|---|
| Tuesday, September 8, 2026, 10:00 am onwards | Group of Investors | One on One / Group meeting | In person | Mumbai |
Indiqube Spaces stated that no unpublished price-sensitive information (UPSI) is intended to be discussed during the interactions. The company noted that changes may occur due to exigencies on the part of the host or the company.
Further details are available on the company’s investor relations website.
Historical Stock Returns for Indiqube Spaces
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.75% | +6.17% | +11.52% | +19.12% | -11.47% | 0.0% |
What specific strategic initiatives or financial performance metrics is Indiqube Spaces likely to highlight to institutional investors during this Mumbai meeting?
How might the outcome of this investor interaction influence Indiqube Spaces' stock volatility and institutional holding patterns in the immediate weeks following September 8?
Given the focus on publicly available information, are there any pending regulatory approvals or project milestones that investors are expected to scrutinize during this session?


































